SEC Form 4 · accession 0001209191-19-009430
Gossamer Bio, Inc. · GOSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bryan Giraudo
Officer — Chief Financial Officer
Period of report
Feb 12, 2019
Accepted (ET)
Feb 12, 2019 · 5:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001728117
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 12, 2019 | C | 17,879 | — | A | 17,879 | D | |
| Common Stock | Feb 12, 2019 | P | 6,000 | $16.00 | A | 23,879 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF1 | — | Feb 12, 2019 | C | 57,142 | D | — | — | Common Stock | 12,698 | 0 | D |
| Series B Preferred StockF1 | — | Feb 12, 2019 | C | 23,316 | D | — | — | Common Stock | 5,181 | 0 | D |
Explanation of responses
- F1The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date.